Loading…

Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic

As the worldwide COVID-19 pandemic unfolded, the clinical and public health community raced to understand SARS-CoV-2 infection and develop life-saving vaccines. Pregnant persons were disproportionately impacted, experiencing more severe illness and adverse pregnancy outcomes. And yet, when COVID-19...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2024-09, Vol.42, p.125644, Article 125644
Main Authors: Meaney-Delman, Dana, Carroll, Sarah, Polen, Kara, Jatlaoui, Tara C., Meyer, Sarah, Oliver, Sara, Gee, Julianne, Shimabukuro, Tom, Razzaghi, Hilda, Riley, Laura, Galang, Romeo R., Tong, Van, Gilboa, Suzanne, Ellington, Sascha, Cohn, Amanda
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c393t-976ecb04310e21c3d7e00c4a940c0e34b5408921d337b94a6bfe33f4a48d42b53
cites cdi_FETCH-LOGICAL-c393t-976ecb04310e21c3d7e00c4a940c0e34b5408921d337b94a6bfe33f4a48d42b53
container_end_page
container_issue
container_start_page 125644
container_title Vaccine
container_volume 42
creator Meaney-Delman, Dana
Carroll, Sarah
Polen, Kara
Jatlaoui, Tara C.
Meyer, Sarah
Oliver, Sara
Gee, Julianne
Shimabukuro, Tom
Razzaghi, Hilda
Riley, Laura
Galang, Romeo R.
Tong, Van
Gilboa, Suzanne
Ellington, Sascha
Cohn, Amanda
description As the worldwide COVID-19 pandemic unfolded, the clinical and public health community raced to understand SARS-CoV-2 infection and develop life-saving vaccines. Pregnant persons were disproportionately impacted, experiencing more severe illness and adverse pregnancy outcomes. And yet, when COVID-19 vaccines became available in late 2020, safety and efficacy data were not available to inform their use during pregnancy because pregnant persons were excluded from pre-authorization clinical trials. Concerns about vaccine safety during pregnancy and misinformation linking vaccination and infertility circulated widely, creating a lack of vaccine confidence. Many pregnant people initially chose not to get vaccinated, and while vaccination rates rose after safety and effectiveness data became available, COVID-19 vaccine acceptance was suboptimal and varied across racial and ethnic distribution of the pregnant population. The COVID-19 pandemic experience provided valuable insights that can inform current and future approaches to maternal vaccination against.
doi_str_mv 10.1016/j.vaccine.2024.01.069
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2934275270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X24000811</els_id><sourcerecordid>3132559948</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-976ecb04310e21c3d7e00c4a940c0e34b5408921d337b94a6bfe33f4a48d42b53</originalsourceid><addsrcrecordid>eNqFkUtv1DAUha0K1E5Lf0KRJTZsEq4febibCoYClSqVBaDuLMe-oR4l9mAnleDXk2GmLNiwOpvvnKtzDyEXDEoGrH6zKR-NtT5gyYHLElgJtToiK9Y2ouAVa5-RFfBaFpLB_Qk5zXkDAJVg6piciFZy0bJ2RR4-DyYEH77TPiY6PSDt52lOSGNPRzNhCmagfhzn4H-ZycdwSd_NfnA7Rwx0wJxjyIuaFNDRPsXxT8r67tvN-4IpujXB4ejtC_K8N0PG84Oeka8frr-sPxW3dx9v1m9vCyuUmArV1Gg7kIIBcmaFaxDASqMkWEAhu0pCqzhzQjSdkqbuehSil0a2TvKuEmfk9T53m-KPGfOkR58tDktNjHPWXAnJm4o3sKCv_kE3cd4VzlowwatKKdkuVLWnbIo5J-z1NvnRpJ-agd5NoTf6MIXeTaGB6WWKxffykD53I7q_rqffL8DVHsDlHY8ek87WY7DofEI7aRf9f078BuvHm6E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3132559948</pqid></control><display><type>article</type><title>Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic</title><source>ScienceDirect Freedom Collection</source><creator>Meaney-Delman, Dana ; Carroll, Sarah ; Polen, Kara ; Jatlaoui, Tara C. ; Meyer, Sarah ; Oliver, Sara ; Gee, Julianne ; Shimabukuro, Tom ; Razzaghi, Hilda ; Riley, Laura ; Galang, Romeo R. ; Tong, Van ; Gilboa, Suzanne ; Ellington, Sascha ; Cohn, Amanda</creator><creatorcontrib>Meaney-Delman, Dana ; Carroll, Sarah ; Polen, Kara ; Jatlaoui, Tara C. ; Meyer, Sarah ; Oliver, Sara ; Gee, Julianne ; Shimabukuro, Tom ; Razzaghi, Hilda ; Riley, Laura ; Galang, Romeo R. ; Tong, Van ; Gilboa, Suzanne ; Ellington, Sascha ; Cohn, Amanda</creatorcontrib><description>As the worldwide COVID-19 pandemic unfolded, the clinical and public health community raced to understand SARS-CoV-2 infection and develop life-saving vaccines. Pregnant persons were disproportionately impacted, experiencing more severe illness and adverse pregnancy outcomes. And yet, when COVID-19 vaccines became available in late 2020, safety and efficacy data were not available to inform their use during pregnancy because pregnant persons were excluded from pre-authorization clinical trials. Concerns about vaccine safety during pregnancy and misinformation linking vaccination and infertility circulated widely, creating a lack of vaccine confidence. Many pregnant people initially chose not to get vaccinated, and while vaccination rates rose after safety and effectiveness data became available, COVID-19 vaccine acceptance was suboptimal and varied across racial and ethnic distribution of the pregnant population. The COVID-19 pandemic experience provided valuable insights that can inform current and future approaches to maternal vaccination against.</description><identifier>ISSN: 0264-410X</identifier><identifier>ISSN: 1873-2518</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2024.01.069</identifier><identifier>PMID: 38423818</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Clinical trials ; COVID-19 ; COVID-19 - epidemiology ; COVID-19 - prevention &amp; control ; COVID-19 vaccines ; COVID-19 Vaccines - administration &amp; dosage ; COVID-19 Vaccines - immunology ; Effectiveness ; Ethnic factors ; Female ; Humans ; Immunization ; Immunization - methods ; Infectious diseases ; Infertility ; Maternal immunization ; Pandemics ; Pandemics - prevention &amp; control ; Pregnancy ; Pregnancy Complications, Infectious - prevention &amp; control ; Public health ; Safety ; SARS-CoV-2 - immunology ; Severe acute respiratory syndrome coronavirus 2 ; Vaccination ; Vaccine ; Vaccines ; Viral diseases ; Womens health</subject><ispartof>Vaccine, 2024-09, Vol.42, p.125644, Article 125644</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier Ltd.</rights><rights>Copyright Elsevier Limited Sep 17, 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-976ecb04310e21c3d7e00c4a940c0e34b5408921d337b94a6bfe33f4a48d42b53</citedby><cites>FETCH-LOGICAL-c393t-976ecb04310e21c3d7e00c4a940c0e34b5408921d337b94a6bfe33f4a48d42b53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38423818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meaney-Delman, Dana</creatorcontrib><creatorcontrib>Carroll, Sarah</creatorcontrib><creatorcontrib>Polen, Kara</creatorcontrib><creatorcontrib>Jatlaoui, Tara C.</creatorcontrib><creatorcontrib>Meyer, Sarah</creatorcontrib><creatorcontrib>Oliver, Sara</creatorcontrib><creatorcontrib>Gee, Julianne</creatorcontrib><creatorcontrib>Shimabukuro, Tom</creatorcontrib><creatorcontrib>Razzaghi, Hilda</creatorcontrib><creatorcontrib>Riley, Laura</creatorcontrib><creatorcontrib>Galang, Romeo R.</creatorcontrib><creatorcontrib>Tong, Van</creatorcontrib><creatorcontrib>Gilboa, Suzanne</creatorcontrib><creatorcontrib>Ellington, Sascha</creatorcontrib><creatorcontrib>Cohn, Amanda</creatorcontrib><title>Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>As the worldwide COVID-19 pandemic unfolded, the clinical and public health community raced to understand SARS-CoV-2 infection and develop life-saving vaccines. Pregnant persons were disproportionately impacted, experiencing more severe illness and adverse pregnancy outcomes. And yet, when COVID-19 vaccines became available in late 2020, safety and efficacy data were not available to inform their use during pregnancy because pregnant persons were excluded from pre-authorization clinical trials. Concerns about vaccine safety during pregnancy and misinformation linking vaccination and infertility circulated widely, creating a lack of vaccine confidence. Many pregnant people initially chose not to get vaccinated, and while vaccination rates rose after safety and effectiveness data became available, COVID-19 vaccine acceptance was suboptimal and varied across racial and ethnic distribution of the pregnant population. The COVID-19 pandemic experience provided valuable insights that can inform current and future approaches to maternal vaccination against.</description><subject>Clinical trials</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - prevention &amp; control</subject><subject>COVID-19 vaccines</subject><subject>COVID-19 Vaccines - administration &amp; dosage</subject><subject>COVID-19 Vaccines - immunology</subject><subject>Effectiveness</subject><subject>Ethnic factors</subject><subject>Female</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization - methods</subject><subject>Infectious diseases</subject><subject>Infertility</subject><subject>Maternal immunization</subject><subject>Pandemics</subject><subject>Pandemics - prevention &amp; control</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - prevention &amp; control</subject><subject>Public health</subject><subject>Safety</subject><subject>SARS-CoV-2 - immunology</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Vaccination</subject><subject>Vaccine</subject><subject>Vaccines</subject><subject>Viral diseases</subject><subject>Womens health</subject><issn>0264-410X</issn><issn>1873-2518</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkUtv1DAUha0K1E5Lf0KRJTZsEq4febibCoYClSqVBaDuLMe-oR4l9mAnleDXk2GmLNiwOpvvnKtzDyEXDEoGrH6zKR-NtT5gyYHLElgJtToiK9Y2ouAVa5-RFfBaFpLB_Qk5zXkDAJVg6piciFZy0bJ2RR4-DyYEH77TPiY6PSDt52lOSGNPRzNhCmagfhzn4H-ZycdwSd_NfnA7Rwx0wJxjyIuaFNDRPsXxT8r67tvN-4IpujXB4ejtC_K8N0PG84Oeka8frr-sPxW3dx9v1m9vCyuUmArV1Gg7kIIBcmaFaxDASqMkWEAhu0pCqzhzQjSdkqbuehSil0a2TvKuEmfk9T53m-KPGfOkR58tDktNjHPWXAnJm4o3sKCv_kE3cd4VzlowwatKKdkuVLWnbIo5J-z1NvnRpJ-agd5NoTf6MIXeTaGB6WWKxffykD53I7q_rqffL8DVHsDlHY8ek87WY7DofEI7aRf9f078BuvHm6E</recordid><startdate>20240917</startdate><enddate>20240917</enddate><creator>Meaney-Delman, Dana</creator><creator>Carroll, Sarah</creator><creator>Polen, Kara</creator><creator>Jatlaoui, Tara C.</creator><creator>Meyer, Sarah</creator><creator>Oliver, Sara</creator><creator>Gee, Julianne</creator><creator>Shimabukuro, Tom</creator><creator>Razzaghi, Hilda</creator><creator>Riley, Laura</creator><creator>Galang, Romeo R.</creator><creator>Tong, Van</creator><creator>Gilboa, Suzanne</creator><creator>Ellington, Sascha</creator><creator>Cohn, Amanda</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20240917</creationdate><title>Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic</title><author>Meaney-Delman, Dana ; Carroll, Sarah ; Polen, Kara ; Jatlaoui, Tara C. ; Meyer, Sarah ; Oliver, Sara ; Gee, Julianne ; Shimabukuro, Tom ; Razzaghi, Hilda ; Riley, Laura ; Galang, Romeo R. ; Tong, Van ; Gilboa, Suzanne ; Ellington, Sascha ; Cohn, Amanda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-976ecb04310e21c3d7e00c4a940c0e34b5408921d337b94a6bfe33f4a48d42b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Clinical trials</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - prevention &amp; control</topic><topic>COVID-19 vaccines</topic><topic>COVID-19 Vaccines - administration &amp; dosage</topic><topic>COVID-19 Vaccines - immunology</topic><topic>Effectiveness</topic><topic>Ethnic factors</topic><topic>Female</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization - methods</topic><topic>Infectious diseases</topic><topic>Infertility</topic><topic>Maternal immunization</topic><topic>Pandemics</topic><topic>Pandemics - prevention &amp; control</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - prevention &amp; control</topic><topic>Public health</topic><topic>Safety</topic><topic>SARS-CoV-2 - immunology</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Vaccination</topic><topic>Vaccine</topic><topic>Vaccines</topic><topic>Viral diseases</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meaney-Delman, Dana</creatorcontrib><creatorcontrib>Carroll, Sarah</creatorcontrib><creatorcontrib>Polen, Kara</creatorcontrib><creatorcontrib>Jatlaoui, Tara C.</creatorcontrib><creatorcontrib>Meyer, Sarah</creatorcontrib><creatorcontrib>Oliver, Sara</creatorcontrib><creatorcontrib>Gee, Julianne</creatorcontrib><creatorcontrib>Shimabukuro, Tom</creatorcontrib><creatorcontrib>Razzaghi, Hilda</creatorcontrib><creatorcontrib>Riley, Laura</creatorcontrib><creatorcontrib>Galang, Romeo R.</creatorcontrib><creatorcontrib>Tong, Van</creatorcontrib><creatorcontrib>Gilboa, Suzanne</creatorcontrib><creatorcontrib>Ellington, Sascha</creatorcontrib><creatorcontrib>Cohn, Amanda</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meaney-Delman, Dana</au><au>Carroll, Sarah</au><au>Polen, Kara</au><au>Jatlaoui, Tara C.</au><au>Meyer, Sarah</au><au>Oliver, Sara</au><au>Gee, Julianne</au><au>Shimabukuro, Tom</au><au>Razzaghi, Hilda</au><au>Riley, Laura</au><au>Galang, Romeo R.</au><au>Tong, Van</au><au>Gilboa, Suzanne</au><au>Ellington, Sascha</au><au>Cohn, Amanda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2024-09-17</date><risdate>2024</risdate><volume>42</volume><spage>125644</spage><pages>125644-</pages><artnum>125644</artnum><issn>0264-410X</issn><issn>1873-2518</issn><eissn>1873-2518</eissn><abstract>As the worldwide COVID-19 pandemic unfolded, the clinical and public health community raced to understand SARS-CoV-2 infection and develop life-saving vaccines. Pregnant persons were disproportionately impacted, experiencing more severe illness and adverse pregnancy outcomes. And yet, when COVID-19 vaccines became available in late 2020, safety and efficacy data were not available to inform their use during pregnancy because pregnant persons were excluded from pre-authorization clinical trials. Concerns about vaccine safety during pregnancy and misinformation linking vaccination and infertility circulated widely, creating a lack of vaccine confidence. Many pregnant people initially chose not to get vaccinated, and while vaccination rates rose after safety and effectiveness data became available, COVID-19 vaccine acceptance was suboptimal and varied across racial and ethnic distribution of the pregnant population. The COVID-19 pandemic experience provided valuable insights that can inform current and future approaches to maternal vaccination against.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>38423818</pmid><doi>10.1016/j.vaccine.2024.01.069</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2024-09, Vol.42, p.125644, Article 125644
issn 0264-410X
1873-2518
1873-2518
language eng
recordid cdi_proquest_miscellaneous_2934275270
source ScienceDirect Freedom Collection
subjects Clinical trials
COVID-19
COVID-19 - epidemiology
COVID-19 - prevention & control
COVID-19 vaccines
COVID-19 Vaccines - administration & dosage
COVID-19 Vaccines - immunology
Effectiveness
Ethnic factors
Female
Humans
Immunization
Immunization - methods
Infectious diseases
Infertility
Maternal immunization
Pandemics
Pandemics - prevention & control
Pregnancy
Pregnancy Complications, Infectious - prevention & control
Public health
Safety
SARS-CoV-2 - immunology
Severe acute respiratory syndrome coronavirus 2
Vaccination
Vaccine
Vaccines
Viral diseases
Womens health
title Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A48%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Planning%20for%20the%20future%20of%20maternal%20immunization:%20Building%20on%20lessons%20learned%20from%20the%20COVID-19%20pandemic&rft.jtitle=Vaccine&rft.au=Meaney-Delman,%20Dana&rft.date=2024-09-17&rft.volume=42&rft.spage=125644&rft.pages=125644-&rft.artnum=125644&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2024.01.069&rft_dat=%3Cproquest_cross%3E3132559948%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c393t-976ecb04310e21c3d7e00c4a940c0e34b5408921d337b94a6bfe33f4a48d42b53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3132559948&rft_id=info:pmid/38423818&rfr_iscdi=true